Our approach to maintaining safety and business continuity during this unprecedented COVID-19 situation.
The medical device industry has traditionally engaged in global manufacturing from a single site. But the most recent geo-political landscape, and especially the global pandemic, has challenged this model of manufacturing medical products from a single site. Cost inefficiencies and discontinuities in the supply chain combined with a rapidly growing medical outsourcing market are giving medical product companies new options in defining their geographic footprint.
Which is the right strategy, regional or global, and what are the considerations? Production volumes, level of vertical integration, specialty components supply, and product shipping challenges are just some of the considerations to factor in. Join our next FlexTalks for a deep dive into these questions.
Spend just 30 minutes to learn more about:
- Key considerations in defining or modifying global manufacturing strategy
- How market forces in supply chain and regulation impact success in production continuity and market penetration
- The pros and cons of each strategy in the current market environment.